Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Coivas
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · Coivas: Check date not recorded
vs
Verdict70/ 100
Grade C · #164Coivas
Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.
Visit CoivasThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 70/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Coivas still earns its place — shoppers who want all-inclusive compounded GLP-1 pricing with a money-back guarantee.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results80
92
Real-world results80
97Price honesty62
97
Price honesty62
96Prescriber access57
96
Prescriber access57
88Formulary choice82
88
Formulary choice82
95Cancellation fairness60
95
Cancellation fairness60
93Member support83
93
Member support83
Price, coverage & features
| Metric | CoreAge Rx | Coivas |
|---|---|---|
| Verdict Score | 94/100 | 70/100 |
| Grade | A | C |
| Semaglutide | $99/mo | From $149/mo (3-mo plan, compounded) |
| Tirzepatide | $149/mo | From $229/mo (3-mo plan, compounded) |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Coivas
What we like
- All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
- Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
- Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
- Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
- Most patients approved in under 2 hours; refund if no provider visit or prescription occurs
The caveats
- Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
- Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
- Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
- No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Shoppers who want all-inclusive compounded GLP-1 pricing with a money-back guarantee.
Visit Coivas Read the full Coivas review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Coivas does the reverse.
More on CoreAge Rx
More on Coivas
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.